Orbimed Advisors - LOXO ONCOLOGY INC ownership

Quarter-by-quarter ownership
Orbimed Advisors ownership history of LOXO ONCOLOGY INC
ValueSharesWeighting
Q3 2018$56,374,000
-39.6%
330,000
-38.7%
0.68%
-39.0%
Q2 2018$93,332,000
-14.0%
538,000
-42.8%
1.11%
-17.3%
Q1 2018$108,563,000
+37.1%
941,000
-99.0%
1.35%
+34.3%
Q4 2017$79,213,000
-50.2%
94,100,036
+5345.6%
1.00%
-34.1%
Q3 2017$159,183,000
+14.9%
1,728,0000.0%1.52%
+4.8%
Q2 2017$138,568,000
+90.6%
1,728,0000.0%1.45%
+76.2%
Q1 2017$72,714,000
+31.0%
1,728,0000.0%0.82%
+16.5%
Q4 2016$55,495,000
+22.7%
1,728,0000.0%0.71%
+37.3%
Q3 2016$45,239,000
-10.3%
1,728,000
-20.6%
0.52%
-2.1%
Q2 2016$50,436,000
-15.2%
2,175,8570.0%0.53%
-16.0%
Q1 2016$59,488,000
-3.9%
2,175,8570.0%0.63%
+11.6%
Q4 2015$61,903,000
+62.8%
2,175,8570.0%0.56%
+46.1%
Q3 2015$38,034,000
-3.1%
2,175,8570.0%0.38%
+33.3%
Q2 2015$39,231,000
+44.8%
2,175,8570.0%0.29%
+24.7%
Q1 2015$27,089,000
+6.0%
2,175,8570.0%0.23%
-5.3%
Q4 2014$25,566,000
-10.5%
2,175,8570.0%0.24%
-18.1%
Q3 2014$28,569,0002,175,8570.30%
Other shareholders

There were no reported owners of LOXO ONCOLOGY INC in Q3 2023.

NameSharesValueWeighting ↓
View complete list of LOXO ONCOLOGY INC shareholders